Literature DB >> 7051453

In vitro demonstration of pyrimethamine resistance of "wild" Plasmodium falciparum in The Gambia.

M E Smalley, J Brown.   

Abstract

The in vitro response of wild Gambian Plasmodium falciparum to pyrimethamine is described. Parasites were grown in 100 microliter cultures through schizogony. The number of rings present after 48 hours in drug-treated cultures was expressed as a percentage of the controls. Neither a medium and drug change after 24 hours nor different starting parasitaemias were found to affect the outcome of the assay, although a medium and drug change did increase the multiplication rate. 60 randomly taken pure P. falciparum infections were studied. 57 were sensitive. The ID50 and ID90 of drug-sensitive infections were 1.7 X 10(-9) M and 4.5 X 10(-9) M pyrimethamine respectively. Three infections were resistant (5%) with individual ID50 values of greater than 10(-6) M, 3 and 4 X 10(-9) M and ID90 values of greater than 10(-6) M, 8 and 9 X 10(-7) M.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7051453     DOI: 10.1016/0035-9203(82)90181-x

Source DB:  PubMed          Journal:  Trans R Soc Trop Med Hyg        ISSN: 0035-9203            Impact factor:   2.184


  3 in total

1.  In vitro sensitivity of southern African reference isolates of Plasmodium falciparum to chloroquine and pyrimethamine.

Authors:  J A Freese; M B Markus; J Golenser
Journal:  Bull World Health Organ       Date:  1991       Impact factor: 9.408

2.  Evaluation of four therapeutic regimens for falciparum malaria in Mozambique, 1986.

Authors:  A Schapira; J F Schwalbach
Journal:  Bull World Health Organ       Date:  1988       Impact factor: 9.408

3.  Consistent signatures of selection from genomic analysis of pairs of temporal and spatial Plasmodium falciparum populations from The Gambia.

Authors:  Alfred Amambua-Ngwa; David Jeffries; Roberto Amato; Archibald Worwui; Mane Karim; Sukai Ceesay; Haddy Nyang; Davis Nwakanma; Joseph Okebe; Dominic Kwiatkowski; David J Conway; Umberto D'Alessandro
Journal:  Sci Rep       Date:  2018-06-26       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.